Free Content

ASH regularly produces educational webinars, video series, and podcasts that feature presentations by experts in the field, cover current information on how to best diagnose and care for patients, and topical discussion on issues relevant to hematology. This content is free to stream on ASH On Demand.


Description

Wendy Stock, MD, discusses the current tools to measure minimal residual disease in acute lymphoblastic leukemia (ALL), how minimal residual disease impacts treatment decisions for ALL, and more. Dr. Stock presented on the topic at the 2016 ASH Meeting on Hematologic Malignancies in a session titled "How I Treat ALL in First Complete Remission: Role of MRD and Molecular Genetics in Treatment Decisions."

Speakers

  • Wendy Stock, MD

Description

David Steensma, MD, discusses current research initiatives in myelodysplastic syndromes, how clonal hematopoiesis of indeterminate potential connects with the development of myeloid neoplasms, and more. Dr. Steensma presented on the topic at the 2016 ASH Meeting on Hematologic Malignancies in a session titled "How I Treat Low Grade MDS." Visit https://ashondemand.org/ for more on this topic and to watch other educational videos from ASH.

Speakers

  • David Steensma, MD

Description

Hetty Carraway, MD, discusses the prognostic scoring system for patients diagnosed with high grade MDS, the role of hypomethylating agents in these patients, how you define treatment response and failure to these agents, and more. Dr. Carraway presented on the topic at the 2016 ASH Meeting on Hematologic Malignancies in a session titled "How I Treat High Grade MDS." Visit https://ashondemand.org/ for more on this topic and to watch other educational videos from ASH.

Speakers

  • Hetty Carraway, MD

Description

Sagar Lonial, MD, discusses the optimal induction for fit myeloma patients, the role for transplant in myeloma treatment, how patients with smoldering myeloma should be assessed, and more. Dr. Lonial presented on the topic at the 2016 ASH Meeting on Hematologic Malignancies in a session titled "How I Treat Newly Diagnosed Multiple Myeloma." Visit https://ashondemand.org/ for more on this topic and to watch other educational videos from ASH.

Speakers

  • Sagar Lonial, MD

Description

Jonathan Friedberg, MD, discusses what's new in the WHO Classification 2016 update for the diagnosis of high grade lymphomas, what's new in the treatment of Burkitt lymphoma, and more. Dr. Friedberg presented on the topic at the 2016 ASH Meeting on Hematologic Malignancies in a session titled "How I Treat Highly Aggressive Lymphomas: Burkitt, Double-Hit, B-Cell, and Unclassifiable with Features Intermediate between DLBCL and Burkitt Lymphoma." Visit https://ashondemand.org/ for more on this topic and to watch other educational videos from ASH.

Speakers

  • Jonathan Friedberg, MD

Description

Jennifer Brown, MD, PhD, discusses combination strategies for high-risk CLL, compelling treatment approaches for achieving and maintaining negative minimal residual disease for patients with high-risk CLL, and more. Dr. Brown presented on the topic at the 2016 ASH Meeting on Hematologic Malignancies in a session titled "How I Treat CLL: High-Risk Genetics." Visit https://ashondemand.org/ for more on this topic and to watch other educational videos from ASH.

Speakers

  • Jennifer Brown, MD, PhD

Description

Ruben Mesa, MD, discusses ruxolitinib, the front-line therapy for patients with myelofibrosis, as well as whether combination therapy should be considered in myelofibrosis, and more. Dr. Mesa presented on the topic at the 2016 ASH Meeting on Hematologic Malignancies in a session titled "How I Treat Myelofibrosis Patients Who Have 'Failed' Ruxolitinib." Visit https://ashondemand.org/ for more on this topic and to watch other educational videos from ASH.

Speakers

  • Ruben Mesa, MD

Description

Paul Richardson, MD, discusses the new therapies for multiple myeloma that were approved by the FDA in November 2015, as well as his participation in the ASH/FDA Joint Symposium on Late-Breaking Drug Approvals at the 2015 ASH Annual Meeting. Visit https://ashondemand.org/ for more on this topic and to watch other educational videos from ASH.

Speakers

  • Paul Richardson, MD

Description

Eric Kraut, MD, discusses the benefits of ASH Teaching Cases and how they can be implemented in a learning environment. Visit https://ashondemand.org/ for more on this topic and to watch other educational videos from ASH.

Speakers

  • Eric Kraut, MD

Description

Vincent Rajkumar, MD, discusses the three myeloma drugs that received FDA approval in November 2015 and how they will affect myeloma therapy. Dr. Rajkumar offered a clinical perspective on the new myeloma drugs at the "ASH/FDA Joint Symposium on Late-Breaking Drug Approvals" at the 57th ASH Annual Meeting. Visit https://ashondemand.org/ for more on this topic and to watch other educational videos from ASH.

Speakers

  • Vincent Rajkumar, MD
1 of 3
back to top